DigestRedComo funciona
Red
/
Empresas
Cl
No verificado

ClearNote Health

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosOncologíaSalud

11 Comunicados de prensa

Ver todos los comunicados de prensa
17/10/2025
Ciencia
Oncología
Técnica
Material médico sanitario
Biotecnología
Medicina - Varios
Cardiología
Salud
Eventos
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
25/09/2025
Industria
Biotecnología
Sanidad
Material médico sanitario
Salud
Oncología
ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
09/07/2025
Oncología
Salud
Material médico sanitario
Medicina - Varios
Farmacéutica
Biotecnología
Industria
ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
16/06/2025
Oncología
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Industria
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
23/04/2025
Eventos
Industria
Técnica
Biotecnología
Medicina - Varios
Cardiología
Salud
Farmacéutica
ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
12/03/2025
Mercado laboral
Industria
Software
Sanidad
Asociaciones/Profesionales
Oncología
Técnica
Biotecnología
Salud
ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
18/02/2025
Ciencia
Biotecnología
Material médico sanitario
Oncología
Sanidad
Salud
Industria
ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
07/01/2025
Análisis de Mercados
Industria
Biotecnología
Salud
Oncología
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
18/12/2024
Industria
Biotecnología
Salud
Medicina - Varios
Oncología
ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population
Fuente
ClearNote Health
Editor
Business Wire
1.00
0
31/10/2024
Industria
Oncología
Salud
Sanidad
Biotecnología
Avantect Pancreatic Cancer Test Cost-Effective When Used as a Surveillance Tool in High-Risk Patients Newly Diagnosed with Diabetes
Fuente
ClearNote Health
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0